Wiley
Wiley.com
Print this page Share
E-book

Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium, Volume 292

Novartis Foundation
ISBN: 978-0-470-69741-2
E-book
222 pages
July 2008
US $169.99 Purchase This E-book

This price is valid for United States. Change location to view local pricing and availability.

Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium, Volume 292 (0470697415) cover image
Important E-book Information
Adobe e-books are read using Adobe Digital Editions. Install Adobe Digital Editions on your PC in order to read or transfer your e-book.
Buy from another retailer for your e-book reader
Other Available Formats: Hardcover

  • This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
  • Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
  • The book integrates information from human and animal studies.
  • The book considers T1D within the broader context of autoimmune disease.
  • The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.